Crizotinib response in a neuroblastoma patient with a constitutional mosaic anaplastic lymphoma kinase I1170N‐activating mutation. Issue 6 (1st February 2021) - Harvey, Melissa; Irwin, Meredith S.; Armstrong, Linlea; Seath, Kim; Young, Sean; Gershony, Sharon; Deyell, Rebecca J.